Tracer Biotechnologies
PrivateLast Round
Series A
Dec 19, 2024
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tracer Biotechnologies is a biotechnology company that has developed a platform for ultrasensitive circulating tumor DNA (ctDNA) monitoring to detect cancer, measure treatment response, and track recurrence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tracer Biotechnologies Comparables
Compare Tracer Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CareDx | 77% | |
| NeoGenomics Inc | 75% | |
| Veracyte | 74% | |
Tracer Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2024 |
Tracer Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Great Oaks Venture Capital | Series A |
| Impatient Ventures | Series A |
| Quiet Ventures | Series A |
| Caffeinated Capital | Series A |
| Exor | Series A |
| Pareto Holdings | Series A |
| Quiet Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 4231% MoM, from 36 to 1.6K.
- Jun 3, 2025
Developing blood-based MRD tests for solid tumors in partnership with QIAGEN.
Tracer Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tracer Biotechnologies's valuation, stock price, and market status.